CEBP CTRC-AACR San Antonio Breast Cancer Symposium 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peluso, M.
Right arrow Articles by Vineis, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peluso, M.
Right arrow Articles by Vineis, P.

Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 4 341-346, Copyright © 1998 by American Association for Cancer Research


ARTICLES

White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study

M Peluso, L Airoldi, M Armelle, T Martone, R Coda, C Malaveille, G Giacomelli, C Terrone, G Casetta and P Vineis
Servizio di Oncologia Sperimentale, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.

We conducted a case-control study on 114 bladder cancer patients and 46 hospital controls. DNA adducts were measured in WBCs by 32P postlabeling and showed no association with smoking habits and the glutathione-S-transferase M1 genotype. A strong association between adduct levels and the N-acetyltransferase (NAT2) genotype was found (P = 0.0002). The NAT2 genotype was associated in a nonstatistically significant way to the case-control status (odds ratio, 1.6; 95% confidence interval, 0.8-3.2). In a logistic regression model, the log of DNA adduct levels was associated in a highly significant way to the risk of bladder cancer (regression coefficient, 0.75; P = 0.0006), independently of smoking habits. Using the median of DNA adducts (RAL, 0.3) as a cutoff point, the odds ratio for the risk of bladder cancer was 4.1 (age-adjusted; 95% confidence interval, 1.9-9.0). Our study suggests that sources other than tobacco smoke contribute to the formation of aromatic DNA adducts in WBCs. The role of WBC-DNA adducts in predicting bladder cancer is still to be clarified.


This article has been cited by other articles:


Home page
Am J EpidemiolHome page
S. Sanderson, G. Salanti, and J. Higgins
Joint Effects of the N-Acetyltransferase 1 and 2 (NAT1 and NAT2) Genes and Smoking on Bladder Carcinogenesis: A Literature-based Systematic HuGE Review and Evidence Synthesis
Am. J. Epidemiol., October 1, 2007; 166(7): 741 - 751.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R.A. Crallan, N.T. Georgopoulos, and J. Southgate
Experimental models of human bladder carcinogenesis
Carcinogenesis, March 1, 2006; 27(3): 374 - 381.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Palli, G. Masala, M. Peluso, L. Gaspari, V. Krogh, A. Munnia, S. Panico, C. Saieva, R. Tumino, P. Vineis, et al.
The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects
Carcinogenesis, April 1, 2004; 25(4): 577 - 584.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. M. Arlt, H. Glatt, E. Muckel, U. Pabel, B. L. Sorg, H. H. Schmeiser, and D. H. Phillips
Metabolic activation of the environmental contaminant 3-nitrobenzanthrone by human acetyltransferases and sulfotransferase
Carcinogenesis, November 1, 2002; 23(11): 1937 - 1945.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. G. Shields
Tobacco Smoking, Harm Reduction, and Biomarkers
J Natl Cancer Inst, October 2, 2002; 94(19): 1435 - 1444.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Airoldi, F. Orsi, C. Magagnotti, R. Coda, D. Randone, G. Casetta, M. Peluso, A. Hautefeuille, C. Malaveille, and P. Vineis
Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies
Carcinogenesis, May 1, 2002; 23(5): 861 - 866.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Garte, L. Gaspari, A.-K. Alexandrie, C. Ambrosone, H. Autrup, J. L. Autrup, H. Baranova, L. Bathum, S. Benhamou, P. Boffetta, et al.
Metabolic Gene Polymorphism Frequencies in Control Populations
Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1239 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. Vineis, D. Marinelli, H. Autrup, J. Brockmoller, I. Cascorbi, A. K. Daly, K. Golka, H. Okkels, A. Risch, N. Rothman, et al.
Current Smoking, Occupation, N-Acetyltransferase-2 and Bladder Cancer: A Pooled Analysis of Genotype-based Studies
Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1249 - 1252.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Matullo, D. Palli, M. Peluso, S. Guarrera, S. Carturan, E. Celentano, V. Krogh, A. Munnia, R. Tumino, S. Polidoro, et al.
XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects
Carcinogenesis, September 1, 2001; 22(9): 1437 - 1445.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. Peluso, M. Ceppi, A. Munnia, R. Puntoni, and S. Parodi
Analysis of 13 32P-DNA Postlabeling Studies on Occupational Cohorts Exposed to Air Pollution
Am. J. Epidemiol., March 15, 2001; 153(6): 546 - 558.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Rundle, D. Tang, J. Zhou, S. Cho, and F. Perera
The Association between Glutathione S-Transferase M1 Genotype and Polycyclic Aromatic Hydrocarbon-DNA Adducts in Breast Tissue
Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1079 - 1085.
[Abstract] [Full Text]


Home page
MutagenesisHome page
L.E. Johns and R.S. Houlston
Glutathione S-transferase {micro}1 (GSTM1) status and bladder cancer risk: a meta-analysis
Mutagenesis, September 1, 2000; 15(5): 399 - 404.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. M. Marcus, R. B. Hayes, P. Vineis, M. Garcia-Closas, N. E. Caporaso, H. Autrup, R. A. Branch, J. Brockmöller, T. Ishizaki, A. E. Karakaya, et al.
Cigarette Smoking, N-Acetyltransferase 2 Acetylation Status, and Bladder Cancer Risk: A Case-Series Meta-analysis of a Gene-Environment Interaction
Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 461 - 467.
[Abstract] [Full Text]


Home page
Toxicol PatholHome page
A. C. Povey
DNA Adducts: Endogenous and Induced
Toxicol Pathol, May 1, 2000; 28(3): 405 - 414.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
M. Peluso, L. Airoldi, C. Magagnotti, L. Fiorini, A. Munnia, A. Hautefeuille, C. Malaveille, and P. Vineis
White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer
Carcinogenesis, February 1, 2000; 21(2): 183 - 187.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.